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FPIN's Clinical Inquiries 
Combined Oral Contraceptives for Mothers Who Are Breastfeeding 
Clinical Question 
Is breastfeeding safe for infants if their mothers use combined oral contraceptives? 
Evidence-Based Answer 
There is currently no evidence of harm; however, few patients have been studied and existing 
studies have many limitations. Therefore, it is not possible to definitively answer this question at 
this time. The existing low-quality evidence suggests that combined oral contraceptives may 
reduce the volume of breast milk but not affect the growth of infants. [Strength of 
Recommendation: B, based on inconsistent or limited-quality patient-oriented evidence] 
Evidence Summary 
Combined oral contraceptives are more effective, more familiar to most patients, and do not have 
to be taken on as strict a schedule as progestin-only pills; however, concern remains about their 
safety for infants of mothers who are taking combined oral contraceptives while breastfeeding. A 
Cochrane systematic review1 on the subject included three trials with 371 patients that compared 
the effects of combined oral contraceptives with a control. The studies were of limited quality 
because they did not specify how the subjects were randomized; the loss-to-follow-up rates were 
high, not reported, or unclear; no sample size calculation was performed in two of the trials; and 
the method of allocation concealment was not reported in two of the trials. 
Two of the trials,2,3 published in 1966 and 1970, compared the effects of combined oral 
contraceptives with placebo and reported conflicting evidence; one study2 reported inhibitory 
effects on milk volume and duration of lactation. The other study3 found no differences in milk 
volume, lactation initiation, or infant growth. The outcomes were not well quantified in either 
study, making it difficult to interpret the data. Further, these two studies2,3 used combined oral 
contraceptives containing high doses of estrogen (from 75 to 80 mcg) that are no longer used. 
The third trial4 reported in the Cochrane review1 compared combined oral contraceptives with 
progestin-only contraceptives. It found statistically significant declines in milk volume in the 
combined oral contraceptive group but no significant differences in infant growth or milk 
composition. Breast milk volume was quantified by pump expression using limited 
measurements. Despite the fact that this was the largest and most recent of the three studies in 
the Cochrane review (it included 171 women and was published in 1984), the data should be 
interpreted with caution because the loss-to-follow-up rate was greater than 30 percent in both 
groups. In addition, most of the participants in the trials were using supplemental feedings by the 
12th week postpartum; these could have masked any detrimental effect the combined oral 
contraceptives had on infant growth. The Cochrane reviewers concluded that the evidence from 
the existing randomized controlled trials was inadequate to make recommendations regarding the 
effects of hormonal contraceptives in lactation. 
Recommendations from Others 
The American College of Obstetricians and Gynecologists recommends that combined oral 
contraceptives should not be initiated before six weeks postpartum, and then only when lactation 
is well established and the infant's nutritional status is well monitored.5 The World Health 
Organization (WHO) recommends against using low-dose combined oral contraceptives in the 
first six weeks postpartum for breastfeeding women. The WHO also does not recommend 
prescribing combined oral contraceptives from six weeks to six months postpartum unless other 
more appropriate methods are not available or not acceptable. After six months postpartum, use 
of low-dose combined oral contraceptives was generally recommended.6 The La Leche League 
International, an advocacy group for breastfeeding, recommends avoiding combined oral 
contraceptives in breastfeeding women because of the other choices available.7 The Physicians' 
Desk Reference advises that a nursing mother should not use oral contraceptives but should use 
other forms of contraception until she has completely weaned her infant.8 
Clinical Commentary 
If combined oral contraceptives are considered after two weeks postpartum (they are relatively 
contraindicated any earlier because of the risk for thromboembolism), mothers who are 
breastfeeding and their physicians should be aware of the potential decrease in breast milk 
volume, the need to monitor the infant's growth, and the alternative forms of available 
contraception. Abstinence, barrier methods such as condoms, and progesterone-only 
contraception such as depo-medroxyprogesterone acetate (Depo-Provera) are possible choices 
immediately postpartum. 
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